Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More news about People's Republic of China
- After a yearslong slump, China's real estate market may be set for a turnaroundA recovery in China's largest cities real estate markets could come as soon as next year, the S&P ratings agency said.
- Uniqlo sees profits soar in China despite Beijing-Tokyo tensionsFast Retailing, the parent company of Japanese clothing retailer Uniqlo, has defied the ongoing political tensions between Beijing and Tokyo and soft consumer sentiment in China to log a rebound in...
- Trump pushed Xi to end Japan freeze, but Chinese leader unmovedUS President Donald Trump pressed Chinese counterpart Xi Jinping during last month’s summit to end a deep freeze in relations with Japan’s Sanae Takaichi, the South China Morning Post reported. Tru...
- China’s AI chipmaker Biren tumbles 12% as it seeks US$510 million in share placementShares of artificial intelligence chipmaker Shanghai Biren Technology tumbled more than 12 per cent in Hong Kong on Thursday amid plans to raise HK$4 billion (US$510 million) through a share placem...
- China has nominated health official Song Li as WHO head - ReutersChina has nominated health official Song Li as WHO head Reuters
- Chinese team says its all-in-one mini artificial pancreas offers next-gen diabetes careChinese scientists have created a wearable all-in-one device combining a glucose sensor and insulin micropump that they say paves the way for a fully autonomous mini artificial pancreas, although i...
- Handelsconfrontatie dreigt: ‘supercruciale’ ontmoeting EU en ChinaPeking is vandaag en morgen het decor van een ontmoeting tussen de Europese Unie en China. Na maanden van oplopende spanningen over de onderlinge handel, ontmoet Eurocommissaris van Handel Sefcovic...
- US AI firm Anthropic enables Chinese-language options for Claude chatbotUS artificial intelligence company Anthropic has introduced Chinese-language options to its Claude chatbot in supported markets, even as it continues to block users from mainland China. Checks by t...